Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy.

Rausch, Johanna; Ullrich, Evelyn; Kühn, Michael W M

Rausch, Johanna; Ullrich, Evelyn; Kühn, Michael W M.

Afiliação

Rausch J; Department of Hematology and Medical Oncology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.
Ullrich E; German Cancer Consortium (DKTK) Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kühn MWM; German Cancer Consortium (DKTK) Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Front Immunol ; 14: 1269012, 2023.

Article em En | MEDLINE | ID: mdl-37809078

Assuntos

Leucemia Mieloide Aguda; Humanos; Leucemia Mieloide Aguda/tratamento farmacológico; Leucemia Mieloide Aguda/genética; Imunoterapia; Azacitidina/uso terapêutico; Resultado do Tratamento; Epigênese Genética

Palavras-chave

acute myeloid leukemia; cellular therapy; checkpoint inhibition; chromatin modifiers; combination therapy; epigenetics; hypomethylating agents; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google